Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy

被引：47
|
作者：
Papamichael, Konstantinos [1 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Ctr Inflammatory Bowel Dis, Boston, MA 02215 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 05期
关键词：
INFLAMMATORY-BOWEL-DISEASE; INDUCTION THERAPY; INFLIXIMAB; MANAGEMENT;
D O I：
10.1038/ajg.2017.21
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：673 / 676
页数：4
相关论文
共 50 条
  • [1] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 149 - 149
  • [2] A UK National Survey of Therapeutic Drug Monitoring With Anti-TNF Medications in IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav B.
    Kontopantelis, Evangelos
    Hayee, Bu
    Limdi, Jimmy K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S443 - S443
  • [3] A UK NATIONAL SURVEY OF THERAPEUTIC DRUG MONITORING WITH ANTI-TNF MEDICATIONS IN IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav
    Kontopantelis, Evan
    Hayee, Bu
    Limdi, Jimmy
    GUT, 2019, 68 : A86 - A87
  • [4] Therapeutic drug monitoring of anti-TNFα drugs in a UK tertiary IBD unit
    Barrow, V.
    Innes, A.
    Thompson, N.
    Mansfield, J.
    Speight, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S416 - S417
  • [5] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [6] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [7] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [8] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
    Rakowsky, Shana
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1049 - 1050
  • [9] Tailoring anti-TNF therapy in IBD: drug levels and disease activity
    Shomron Ben-Horin
    Yehuda Chowers
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 : 243 - 255
  • [10] Tailoring anti-TNF therapy in IBD: drug levels and disease activity
    Ben-Horin, Shomron
    Chowers, Yehuda
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2014, 11 (04) : 243 - 255
12345